Comparison of the Continuation Rate of Twice-Weekly and Weekly Teriparatide Administration in a Rural Area

This publication has 22 references indexed in Scilit:

• Treatment persistence and changes in fracture risk, back pain, and quality of life amongst patients treated with teriparatide in routine clinical care in France: Results from the European Forsteo Observational Study
  Joint Bone Spine, 2014
• The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis
  Osteoporosis International, 2013
• Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk
  The Journal of Clinical Endocrinology & Metabolism, 2012
• Parathyroid Hormone 1-84 Accelerates Fracture-Healing in Pubic Bones of Elderly Osteoporotic Women
  Journal of Bone and Joint Surgery, 2011
• Adherence and persistence in patients with severe osteoporosis treated with teriparatide
  Current Medical Research and Opinion, 2010
• Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis
  Osteoporosis International, 2009
• The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates
  Current Medical Research and Opinion, 2007
• Persistence with teriparatide in patients with osteoporosis: the UK experience
  Osteoporosis International, 2006
• Intermittent Parathyroid Hormone (1–34) Treatment Increases Callus Formation and Mechanical Strength of Healing Rat Fractures
  Journal of Bone and Mineral Research, 1999
• Perspective how many women have osteoporosis?
  Journal of Bone and Mineral Research, 1992